17β-Estradiol induces ERβ up-regulation via p38/MAPK activation in colon cancer cells

Biochemical and Biophysical Research Communications

Volumn 359, Issue 1, 2007, Pages 102-107

  Caiazza, Francesco ^a   Galluzzo, Paola ^a   Lorenzetti, Stefano ^b   Marino, Maria ^a  

^a ROMA TRE UNIVERSITY   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

17 Estradiol; Colon cancer cells; Estrogen receptor ; Non genomic signals; p38 MAPK

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR BETA; MITOGEN ACTIVATED PROTEIN KINASE P38;

ARTICLE; CANCER CELL; CANCER INHIBITION; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA TRANSLATION; SIGNAL TRANSDUCTION; UPREGULATION; ADENOCARCINOMA; CELL PROLIFERATION; COLON TUMOR; DOSE RESPONSE; DRUG EFFECT; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN RECEPTOR BETA; HUMANS; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; UP-REGULATION;

EID: 34249712435     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.05.059     Document Type: Article

References (34)

1. Ascenzi P., Bocedi A., and Marino M. Structure-function relationship of estrogen receptor α and β: impact on human health. Mol. Aspects Med. 27 (2006) 299-402
2. Kuiper G.G., and Gustafsson J.-Å. The novel estrogen receptor-β subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett. 410 (1997) 87-90
3. Deroo B.J., and Korach K.S. Estrogen receptors and human disease. J. Clin. Invest. 116 (2006) 561-570
4. Matthews J., and Gustafsson J.-Å. Estrogen signalling: a subtle balance between ERα and ERβ. Mol. Interv. 3 (2003) 281-292
5. Castoria G., Migliaccio A., Bilancio A., Di Domenico M., de Falco A., Lombardi M., Fiorentino R., Varricchio L., Barone M.V., and Auricchio F. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J. 20 (2001) 6050-6059
6. 1 gene transcription in HepG2 cells. Mol. Biol. Cell 13 (2002) 3720-3729
7. Marino M., Acconcia F., and Trentalance A. Biphasic estradiol induced AKT-phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells. Mol. Biol. Cell 14 (2003) 2583-2591
8. Konstantinopoulos P.A., Kominea A., Vandoros G., Sykiotis G.P., Andricopoulos P., Varakis I., Sotiropoulou-Bonikou G., and Papavassiliou A.G. Oestrogen receptor beta (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur. J. Cancer 39 (2003) 1251-1258
9. Bardin A., Boulle N., Lazennec G., Vignon F., and Pujol P. Loss of ERβ expression as a common step in estrogen-dependent tumor progression. Endocr. Relat. Cancer 11 (2004) 537-551
10. Jassam N., Bell S.M., Speirs V., and Quirke P. Loss of expression of oestrogen receptor β in colon cancer and its association with Dukes' staging. Oncol. Rep. 14 (2005) 17-21
11. Marino M., Galluzzo P., Leone S., Acconcia F., and Ascenzi P. Nitric oxide impairs the 17β-estradiol-induced apoptosis in human colon adenocarcinoma cells. Endocr. Relat. Cancer 13 (2006) 559-569
12. Wada-Hiraike O., Imamov O., Hiraike H., Hultenby K., Schwend T., Omoto Y., Warner M., and Gustafsson J.-Å. Role of estrogen receptor β in colonic epithelium. Proc. Natl. Acad. Sci. USA 103 (2006) 2959-2964
13. Galluzzo P., Caiazza F., Moreno S., and Marino M. Role of ERβ palmitoylation in the inhibition of human colon cancer cell proliferation. Endocr. Relat. Cancer 14 (2007) 153-167
14. Jensen E.V. Mechanism of estrogen action in relation to carcinogenesis. Proc. Can. Cancer Conf. 6 (1965) 143-165
15. Nirmala P.B., and Thampan R.V. Ubiquitination of the rat uterine estrogen receptor: dependence on estradiol. Biochem. Biophys. Res. Commun. 213 (1995) 24-31
16. Reid G., Hubner M.R., Métivier R., Brand H., Denger S., Manu D., Beaudouin J., Ellenberg J., and Gannon F. Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling. Mol. Cell 11 (2003) 695-707
17. Vladusic E.A., Hornby A.E., Guerra-Vladusic F.K., and Lupu R. Expression of estrogen receptor beta messenger RNA variant in breast cancer. Cancer Res. 58 (1998) 210-214
18. Pravettoni A., Mornati O., Martini P.G., Marino M., Colciago A., Celotti F., Motta M., and Negri-Cesi P. Estrogen receptor beta (ERβ) and inhibition of prostate cancer cell proliferation: studies on the possible mechanism of action in DU145 cells. Mol. Cell. Endocrinol. 263 (2007) 46-54
19. Ing N.H. Steroid hormones regulate gene expression posttranscriptionally by altering the stabilities of messenger RNAs. Biol. Reprod. 72 (2005) 1290-1296
20. Mitchell D.C., and Ing N.H. Estradiol stabilizes estrogen receptor messenger ribonucleic acid in sheep endometrium via discrete sequence elements in its 3′-untranslated region. Mol. Endocrinol. 17 (2003) 562-574
21. Chambliss K.L., and Shaul P.W. Rapid activation of endothelial NO synthase by estrogen: evidence for a steroid receptor fast-action complex (SRFC) in caveolae. Steroids 67 (2002) 413-419
22. Levin E.R. Integration of the extra-nuclear and nuclear actions of estrogen. Mol. Endocrinol. 19 (2005) 1951-1959
23. Kampa M., and Castanas E. Membrane steroid receptor signaling in normal and neoplastic cells. Mol. Cell. Endocrinol. 246 (2006) 76-82
24. Zhang D., and Trudeau V.L. Integration of membrane and nuclear estrogen receptor signaling. Comp. Biochem. Physiol. A. Mol. Integr. Physiol. 144 (2006) 306-315
25. Marino M., Ascenzi P., and Acconcia F. S-palmitoylation modulates estrogen receptor α localization and functions. Steroids 71 (2006) 298-303
26. Leclercq G., Lacroix M., Laios I., and Laurent G. Estrogen receptor α: impact of ligands on intracellular shuttling and turnover rate in breast cancer cells. Curr. Cancer Drug Targets 6 (2006) 39-64
27. Warner M., and Gustafsson J.-Å. Nongenomic effects of estrogen: why all the uncertainty?. Steroids 71 (2006) 91-95
28. Castoria G., Barone M.V., Di Domenico M., Bilancio A., Ametrano D., Migliaccio A., and Auricchio F. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J. 18 (1999) 2500-2510
29. Matthews J., Wihlen B., Tujague M., Wan J., Strom A., and Gustafsson J.-Å. Estrogen receptor (ER) β modulates ERα-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters. Mol. Endocrinol. 20 (2006) 534-543
30. Strom A., Hartman J., Foster J.S., Kietz S., Wimalasena J., and Gustafsson J.-Å. Estrogen receptor β inhibits 17-β-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc. Natl. Acad. Sci. USA 101 (2004) 1566-1571
31. Paruthiyil S., Parmar H., Kerekatte V., Cunha G.R., Firestone G.L., and Leitman D.C. Estrogen receptor β inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res. 64 (2004) 423-428
32. Acconcia F., Ascenzi P., Bocedi A., Spisni E., Tomasi V., Trentalance A., Visca P., and Marino M. Palmitoylation-dependent estrogen receptor α membrane localization: regulation by 17β-estradiol. Mol. Biol. Cell 16 (2005) 231-237
33. Kontoyiannis D., Kotlyarov A., Carballo E., Alexopoulou L., Blackshear P.J., Gaestel M., Davis R., Flavell R., and Kollias G. Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J. 20 (2001) 3760-3770
34. Vasudevan S., Garneau N., Tu Khounh D., and Peltz S.W. p38 mitogen-activated protein kinase/Hog1p regulates translation of the AU-rich-element-bearing MFA2 transcript. Mol. Cell. Biol. 25 (2005) 9753-9763